JP2015110565A5 - - Google Patents

Download PDF

Info

Publication number
JP2015110565A5
JP2015110565A5 JP2014237028A JP2014237028A JP2015110565A5 JP 2015110565 A5 JP2015110565 A5 JP 2015110565A5 JP 2014237028 A JP2014237028 A JP 2014237028A JP 2014237028 A JP2014237028 A JP 2014237028A JP 2015110565 A5 JP2015110565 A5 JP 2015110565A5
Authority
JP
Japan
Prior art keywords
salt
water
nanodispersion
sterol
docetaxel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014237028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015110565A (ja
JP5937180B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015110565A publication Critical patent/JP2015110565A/ja
Publication of JP2015110565A5 publication Critical patent/JP2015110565A5/ja
Application granted granted Critical
Publication of JP5937180B2 publication Critical patent/JP5937180B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014237028A 2007-12-24 2014-11-21 ナノ分散体 Expired - Fee Related JP5937180B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2527MU2007 2007-12-24
IN2527/MUM/2007 2007-12-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010540226A Division JP5656643B2 (ja) 2007-12-24 2008-12-23 ナノ分散体

Publications (3)

Publication Number Publication Date
JP2015110565A JP2015110565A (ja) 2015-06-18
JP2015110565A5 true JP2015110565A5 (https=) 2016-04-21
JP5937180B2 JP5937180B2 (ja) 2016-06-22

Family

ID=40853553

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010540226A Active JP5656643B2 (ja) 2007-12-24 2008-12-23 ナノ分散体
JP2014237028A Expired - Fee Related JP5937180B2 (ja) 2007-12-24 2014-11-21 ナノ分散体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010540226A Active JP5656643B2 (ja) 2007-12-24 2008-12-23 ナノ分散体

Country Status (20)

Country Link
US (2) US8586062B2 (https=)
EP (2) EP2231144B1 (https=)
JP (2) JP5656643B2 (https=)
KR (1) KR101505419B1 (https=)
CN (1) CN101909614B (https=)
AP (1) AP2895A (https=)
AU (1) AU2008346121B2 (https=)
BR (1) BRPI0821514B8 (https=)
CA (1) CA2710525C (https=)
CO (1) CO6290681A2 (https=)
DK (1) DK2231144T3 (https=)
EA (1) EA016434B1 (https=)
ES (1) ES2509490T3 (https=)
IL (1) IL206584A0 (https=)
MX (1) MX2010007076A (https=)
NZ (1) NZ586343A (https=)
PL (1) PL2231144T3 (https=)
UA (1) UA100543C2 (https=)
WO (1) WO2009087678A2 (https=)
ZA (1) ZA201004450B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2442805A4 (en) * 2009-06-19 2012-11-21 Sun Pharma Advanced Res Co Ltd NANODISPERSION OF A MEDICINE AND METHOD FOR PREPARING THE SAME
CN102038635A (zh) * 2009-10-23 2011-05-04 天津天士力集团有限公司 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
KR20110056042A (ko) * 2009-11-20 2011-05-26 주식회사유한양행 종양세포 표적지향을 위한 나노 입자 및 이의 제조방법
US10842770B2 (en) 2010-05-03 2020-11-24 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
ES2385995B2 (es) 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
CN102078300B (zh) * 2011-01-27 2012-01-11 海南美大制药有限公司 托拉塞米脂质体固体制剂
CN102366409B (zh) * 2011-09-14 2013-03-20 海南灵康制药有限公司 一种尼扎替丁脂质体固体制剂
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
BR112015022231B1 (pt) * 2013-03-14 2020-11-24 Griffith Laboratories International, Inc. Metodo para tratamento de fungos que causam sigatoka negra em plantaqoes da familia musaceae
EP3148331B1 (en) * 2014-05-30 2020-12-23 OMS Investments, Inc. Methods of making nano-sized water-based dispersion compositions
KR101692314B1 (ko) * 2015-03-27 2017-01-03 주식회사 주빅 지용성 약물의 생분해성 고분자 내 용해 시스템: 스마트 폴리머 시스템
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
US11304898B2 (en) 2015-06-09 2022-04-19 Sun Pharma Advanced Research Company Ltd Method of treating carcinoma
CN107551390A (zh) * 2017-08-21 2018-01-09 常熟佳禾生物科技有限公司 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法
AU2019239073B2 (en) * 2018-03-19 2024-12-05 Epicyt Pharma Ab A composition for use in the treatment of conditions caused by calcium deficiency
US11423574B2 (en) 2019-12-17 2022-08-23 Emma Ruccio Method and apparatus for detecting scoliosis
US11877717B2 (en) 2019-12-17 2024-01-23 Emma Ruccio Method and apparatus for detecting scoliosis
ES2984690T3 (es) * 2020-06-26 2024-10-30 Algiax Pharmaceuticals Gmbh Composición de nanopartículas
JP7745863B2 (ja) * 2021-04-12 2025-09-30 国立大学法人広島大学 難水溶性物質の可溶化方法および難水溶性物質の可溶化組成物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018A (en) * 1849-01-09 Improvement in bog-cutters
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR19990075621A (ko) * 1998-03-23 1999-10-15 임성주 경사 평판형 배양조
US6017948A (en) 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6365191B1 (en) * 1999-02-17 2002-04-02 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
ATE347886T1 (de) * 1999-09-23 2007-01-15 Dabur Pharma Ltd Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
TWI230616B (en) 2000-09-25 2005-04-11 Ind Tech Res Inst Liposome for incorporating large amounts of hydrophobic substances
JP2004529934A (ja) * 2001-05-01 2004-09-30 アンジオテック ファーマシューティカルズ,インコーポレイテッド 抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用
DE10124952A1 (de) * 2001-05-21 2002-12-12 Bayer Ag Verfahren zur Herstellung von Nanodispersionen
WO2003045357A1 (en) * 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20050288521A1 (en) * 2004-06-29 2005-12-29 Phytogen Life Sciences Inc. Semi-synthetic conversion of paclitaxel to docetaxel
JP2008531591A (ja) * 2005-02-24 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド ドセタキセルおよびそれらの類似体のナノ粒子製剤
JP2008543789A (ja) 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー ドセタキセルの液体薬学的処方物
BRPI0617663A2 (pt) * 2005-10-21 2011-08-02 Panacea Biotec Ltd composições aperfeiçoadas para terapia de cáncer
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof

Similar Documents

Publication Publication Date Title
JP2015110565A5 (https=)
DK3458074T3 (da) COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
EP3267964A4 (en) Peg free stable low viscosity oil-in-water emulsion and use thereof
LT3313829T (lt) Lipidai ir lipidų nanodalelių sudėtys, skirtos nukleorūgščių tiekimui
JP2015157148A5 (ja) 皮膚用針
JP2017514877A5 (https=)
JP2014179090A5 (https=)
JP2014156601A5 (https=)
HUE053116T2 (hu) Eljárás vízben oldhatatlan vagy vízben rosszul oldódó hatóanyagok vízoldhatóságának javítására
BR112017005126A2 (pt) compostos citotóxicos e antimitóticos e métodos de uso dos mesmos.
Leiter et al. Conquering burnout
EP3555127C0 (en) AGENTS, USES AND METHODS
PL3658594T3 (pl) Stabilne wodne dyspersje polimerowe
HUE064432T2 (hu) Stabil folyékony gonadotropin készítmény
EP3433598C0 (fr) Billes solubles pour la préparation de solutions
Yuan et al. The theory of intuitionistic fuzzy sets based on the intuitionistic fuzzy special sets
MX387903B (es) Proceso para la preparacion de acidos 3-hidroxipicolinicos.
EA201692044A1 (ru) Композиция и способ получения наносостава водонерастворимых биоактивных соединений на водной основе
IL263994B (en) Novel processes for preparation of soluble guanylate cyclase stimulators
EP3109242B8 (en) Water-soluble taxane derivatives and uses thereof
EP3596175A4 (en) NANOPARTICLES FOR THE ADMINISTRATION OF CHEMOPREVENTIVE AGENTS
JP2015174850A5 (https=)
MX376150B (es) Método de desbarbado y aparato de desbarbado.
Donadze et al. Bazzoni–Glaz conjecture
Navas-Cuéllar et al. Neuroendocrine carcinoma of the common bile duct